SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 174 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $36,000 | -16.3% | 10,500 | 0.0% | 0.00% | -25.0% |
Q3 2020 | $43,000 | +22.9% | 10,500 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $35,000 | +45.8% | 10,500 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $24,000 | -63.1% | 10,500 | -41.3% | 0.00% | -57.1% |
Q4 2019 | $65,000 | -56.1% | 17,900 | 0.0% | 0.01% | -58.8% |
Q3 2019 | $148,000 | -9.8% | 17,900 | -6.0% | 0.02% | -5.6% |
Q2 2019 | $164,000 | -19.2% | 19,050 | 0.0% | 0.02% | -21.7% |
Q1 2019 | $203,000 | +18.0% | 19,050 | -3.1% | 0.02% | 0.0% |
Q4 2018 | $172,000 | -47.9% | 19,650 | 0.0% | 0.02% | -36.1% |
Q3 2018 | $330,000 | -19.9% | 19,650 | 0.0% | 0.04% | -25.0% |
Q2 2018 | $412,000 | +43.1% | 19,650 | +9.8% | 0.05% | +41.2% |
Q1 2018 | $288,000 | -17.9% | 17,900 | -3.2% | 0.03% | -20.9% |
Q4 2017 | $351,000 | +34.5% | 18,500 | 0.0% | 0.04% | +26.5% |
Q3 2017 | $261,000 | +89.1% | 18,500 | 0.0% | 0.03% | +78.9% |
Q2 2017 | $138,000 | – | 18,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,177,115 | $1,495,000 | 1.27% |
ARMISTICE CAPITAL, LLC | 9,665,756 | $12,276,000 | 0.20% |
CM Management, LLC | 150,000 | $191,000 | 0.14% |
FSB PREMIER WEALTH MANAGEMENT, INC. | 200,000 | $254,000 | 0.11% |
Manteio Capital LLC | 57,586 | $73,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 410,691 | $522,000 | 0.07% |
SYNTAX ADVISORS, LLC | 29,181 | $37,000 | 0.03% |
CAXTON ASSOCIATES LP | 164,096 | $208,000 | 0.02% |
Alpine Global Management, LLC | 97,650 | $124,000 | 0.02% |
Sonora Investment Management Group, LLC | 82,000 | $104,000 | 0.01% |